Biotech Venture Capitalist Jeffrey Sollender To Keynote Informed Investors Forum In San Diego Saturday July 31.SAN DIEGO--(BUSINESS WIRE)--July 22, 1999-- Investing in biotech companies is both an art and a science, with potential risks to match the potential rewards, according to Jeffrey Sollender, a founder and partner in Forward Ventures, a San Diego venture capital firm with $55 million under management. Sollender will give investors the private-equity view of opportunities, trends and analysis of the biotech sector in his keynote address "Putting the Private Eye on Biotech: How Venture Capital Views The Sector." Sollender is the headliner at the Fifth Informed Investors BioMedical Stocks Forum Saturday morning July 31 at the Mission Valley Radisson. The Forum runs from 8:30 a.m.-1 p.m. Admission is $25 prepaid. Register at www.informedinvestors.com or call 800-992-4683. In addition to Sollender, individual investors will hear presentations from executives of five public companies: Joseph Rubinfeld, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of SuperGen (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :SUPG SUPG Streamline Upwind Petrov Galerkin ); Ed Quilty, CEO of Palatin (NASDAQ:PLTN PLTN Platoon PLTN Pembangkit Listrik Tenaga Nuklir (Indonesia) ); Gerry Willis, CFO See Chief Financial Officer. of Trega BioSciences (NASDAQ:TRGA); Debby Jo Blank, M.D., Executive Vice President of Isis Pharmaceuticals (NASDAQ:ISIP ISIP Institute for Signal and Information Processing ISIP Intelligent Storage Interconnect Platform ISIP Intermediate-Size Inducer Pump ISIP Initiative for State Infrastructure Protection ISIP Information Sharing Integration Platform ISIP Integrated Signal/Information Processing ); and Vince Reardon, IR Director of IDEC IDEC Instituto Brasileiro de Defesa do Consumidor (Portugese: Brazilian Consumer Protection Agency) IDEC Information Design & End-User Computing IDEC Interior Design Educators Council, Inc. Pharmaceuticals (NASDAQ:IDPH IDPH Illinois Department of Public Health IDPH Iowa Department of Public Health ). Presentations follow the style given to institutional investors. Sollender has been a venture capitalist since 1988. He is a founder of a number of Forward companies, private and publicly-held, including AriZeke Pharmaceuticals, CombiChem (NASDAQ:CCHM CCHM Century Campus Housing Management CCHM Cherokee County Historical Museum CCHM CombiChem Inc (stock symbol) CCHM Centre Culturel Haut-Marnais (French) CCHM Certificate in Chinese Herbal Medicine ), Triangle Pharmaceuticals (NASDAQ:VIRS), GenQuest, now Corixa (NASDAQ:CRXA) and Nereus Pharmaceuticals. Through Forward Ventures, Sollender is an advisor to Biotechvest which has investments in companies including Lynx Therapeutics (NASDAQ:LYNX), Abgenix, Desmos, Exelixis Pharmaceuticals, Gene Logic (NASDAQ:GLGC) and XTL. Prior to launching Biotechvest and joining Forward Ventures, Sollender was a part of William Farley's corporate development/mergers and acquisitions team at Farley Industries and provided management consulting services to technology-based companies at Booz, Allen & Hamilton. Sollender serves as the acting Chairman and CEO of AriZeke Pharmaceuticals, a company founded by Forward Ventures. He also serves on the Board of Directors for Variagenics, Gene Logic, Desmos, Ciblex, Genicon, XTL and Dynavax. (Investors interested in biotechnology may wish to hear today's Internet-based Informed Investors Radio Forum from 2-3 p.m. Eastern time (11-noon PDT). Go to the Informed Investors website and click through. Guests are Jay Silverman, senior biotech analyst at BancBoston Robertson Stephens, and Jim McCamant, longtime editor of the Medical Technology Stocks Letter.) Informed Investors is also hosting its Seventh SF Bay Area Biotech Stocks Forum on Saturday July 24 at the Berkeley Radisson. Craig Parker, vice president and senior biotechnology analyst at Donaldson Lufkin Jenrette, keynotes the Forum along with analyst-style presentations by executives of several biotech companies. The Forum runs from 8:30-12:30 p.m. Cost is $25 prepaid. Register at the web site or call 800-992-4683. Informed Investors Forum is the leading producer of industry-specific investment conferences for individual investors and has featured hundreds of quality companies and scores of industry experts at its Forums. |
|
|||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion